Study Stopped
Subject recruitment unable to be completed due to study feasibility issues.
Use of Rotational Thromboelastometry (ROTEM) to Characterize Coagulation Abnormalities in Burn Patients
1 other identifier
interventional
2
1 country
1
Brief Summary
This is an interventional pilot study of 40 burn inpatients. Specific aims of the proposed pilot study are to use bedside blood analysis with rotational thromboelastometry (ROTEM) in severe burn patients to provide preliminary information on the nature of coagulation abnormalities and compare subject ROTEM coagulation profiles within 24 hours of burn injury (day 1) and on days 2, 3, 5, 7, 14 and 21 after burn injury.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedFirst Submitted
Initial submission to the registry
February 2, 2015
CompletedFirst Posted
Study publicly available on registry
March 17, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedResults Posted
Study results publicly available
April 19, 2018
CompletedJuly 5, 2018
June 1, 2018
1.4 years
February 2, 2015
October 25, 2017
June 5, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Coagulation Parameters
To compare ROTEM coagulation parameters involving fibrin contribution to clot formation (FIBTEM) between patients on admission/enrollment (day 1), and on days 2, 3, 5, 7, 14 and 21 after burn injury to see if expected hypercoagulability shows evidence of resolution.
21 days
Secondary Outcomes (1)
Predictive Value of ROTEM Data
21 days
Study Arms (1)
ROTEM
EXPERIMENTALClinical burn ICU Inpatients receiving blood draws for ROTEM analysis and fibrinogen levels.
Interventions
A blood sample and reagents are placed into a small cup. A pin suspended from a wire is immersed into the sample. The pin rotates back and forth at a fixed angle. The movement of the pin is optically monitored and converted into a real time measurement that is represented graphically. Prior to clot formation, pin rotation is unhindered and is graphically represented as a straight line. As the subject's blood sample starts to clot, strands of clot form between the pin and the cup wall, restricting the movement of the pin depending on the strength of the clot. Graphically, this is represented as a symmetrical widening of the curve.
Eligibility Criteria
You may qualify if:
- Consecutive patients admitted to NYPH with 15% TBSA burn or greater.
- Patients with vascular access catheters (arterial or central line) placed within 24 hours of burn injury
- Males and females
- Ages \>3 years or \>15 kg
- Informed verbal consent obtained from the patient or the patient's designated health care proxy (DHCP). In the case of minors, assent and informed verbal consent obtained from at least one parent or guardian.
You may not qualify if:
- Known pre-existing hemostatic abnormalities
- Ages \< 3 years or weight \< 15 kg
- Intake of anticoagulants or antiplatelet aggregation inhibitors prior to burn
- Pregnant patients
- Patients with delayed presentation (greater than 24 hours after burn injury)
- Refusal or inability of patient or patient's DHCP to consent in English.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Weill Cornell Medical College
New York, New York, 10065, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Early termination leading to small numbers of subjects analyzed. Small numbers of subjects due to the critical condition of subject population.
Results Point of Contact
- Title
- Christine Lennon, M.D.
- Organization
- Weill Cornell Medicine
Study Officials
- PRINCIPAL INVESTIGATOR
Christine Lennon, MD
Weill Medical College of Cornell University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 2, 2015
First Posted
March 17, 2015
Study Start
January 1, 2015
Primary Completion
June 1, 2016
Study Completion
June 1, 2016
Last Updated
July 5, 2018
Results First Posted
April 19, 2018
Record last verified: 2018-06
Data Sharing
- IPD Sharing
- Will not share
There is no plan to share IPD